Clinical diagnosis and prognosis of pulmonary thromboembolism


Cite item

Full Text

Abstract

Pulmonary thromboembolism (PTE) is a nosological entity that complicates the course of many diseases. This circumstance determines difficulties in the diagnosis and determination of further patient management tactics. Bolus-enhanced computed tomography of pulmonary arteries, a method having high resolution and high accuracy, is presently accepted to be the gold standard to verify the diagnosis. At the same time this radiocontrast study cannot be used as a screening tool by economic and other reasoning, which determines the importance of the clinical diagnosis of the disease. This review considers different approaches to diagnosing PTE and a base of elaborated clinical algorithms and comparatively assesses empirical and scoring systems for the diagnosis and prediction of a disease course characterized by the rapidness and unpredictability of an outcome even in correctly made diagnosis.

Full Text

Клиническая диагностика и прогноз тромбоэмболии легочных артерий. - Аннотация. Тромбоэмболия легочных артерий (ТЭЛА) - нозологическая форма, осложняющая течение многих заболеваний. Данное обстоятельство определяет трудности диагностики и определения дальнейшей тактики ведения пациентов. "Золотым стандартом" верификации диагноза в настоящее время принята компьютерная томография с болюсным усилением легочных артерий - метод, обладающий высокой разрешающей способностью и точностью. Между тем в силу экономических и других соображений подобное рентгеноконтрастное исследование не может быть использовано в качестве скринингового, что и определяет важность клинической диагностики заболевания. В обзоре рассмотрены различные подходы к диагностике ТЭЛА и база созданных клинических алгоритмов, проведена сравнительная оценка эмпирической и балльной систем диагностики и прогноза течения заболевания, характеризующегося скоротечностью и непредсказуемостью исхода даже при верно поставленном диагнозе.
×

References

  1. Steven N. Goodman Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy Ann Intern Med 1999; 130: 995-1004.
  2. Moye´ L. End-point interpretation in clinical trials: the case for discipline. Control Clin Trials 1999; 20: 40-49.
  3. Fisher L.D. Carvedilol and the Food and Drug Administration (FDA) approval process: the FDA paradigm and reflections on hypothesis testing. Control Clin Trials 1999; 20: 16-39.
  4. Fisher L., Moye´ L. Carvedilol and the Food and Drug Administration (FDA) approval process: an introduction. Control Clin Trials 1999; 20: 1-15.
  5. Fisher L.D. Comments on Bayesian and frequentist analysis and interpretation of clinical trials. Control Clin Trials 1996; 17: 423-434.
  6. Brophy J.M., Joseph L. Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA 1995; 273: 871-875.
  7. Wulff H.R., Anderson B., Brandenhoff P., Guttler F. What do doctors know about statistics? Stat Med 1987; 6: 3-10.
  8. Borak J., Veilleux S. Errors of intuitive logic among physicians. Soc Sci Med 1982; 16: 1939-1947.
  9. Concato J., Feinstein A.E., Holford T.R. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118: 201-210.
  10. White R.H. The Epidemiology of Venous Thromboembolism. Circulation 2003; 107: I-4-I-8.
  11. Cushman M., Tsai A.W., White R.H. et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
  12. Kroegel C. Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 2003; 70 (1): 7-30.
  13. The Columbus Investigators Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-662.
  14. Goldhaber S.Z., Visani L., De R.M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
  15. Anderson F.A. Jr, Wheeler H.B., Goldberg R.J. et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
  16. Heit J.A., Silverstein M.D., Mohr D.N. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-453.
  17. Kniffin W.D. Jr, Baron J.A., Barrett J. et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-866.
  18. Pinede L., Ninet J., Duhaut P. et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453-2460.
  19. Douketis J.D., Foster G.A., Crowther M.A. et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000; 160: 3431-3436.
  20. Hull R.D., Raskob G.E., Pineo G.F. et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326: 975-982.
  21. Simonneau G., Sors H., Charbonnier B. et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997; 337: 663-669.
  22. Horlander K.T., Mannino D.M., Leeper K.V. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003; 163: 1711-1717.
  23. Siddique R.M., Siddique M.I., Connors A.F. Jr, Rimm A.A. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med 1996; 156: 2343-2437.
  24. Dalen J.E., Alpert J.S. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17: 259-270.
  25. Dalen J.E., Brooks H.L., Johnson L.W. et al. Pulmonary angiography in acute pulmonary embolism: indications, techniques, and results in 367 patients. America 1971; 81: 175-185.
  26. Rosen M.P., Sands D.Z., Moris J. et al. Does a physician's ability to accurately assess the likelihood of pulmonary embolism increase with training? Acad Med 2000; 75: 1199-1205.
  27. Morabia A., Steinig-Stamm M., Unger P. et al. Applicability of decision analysis to everyday clinical practice. J Gen Intern Med 1994; 9: 496-502.
  28. Wells P.S., Hirsh J., Anderson D.R. et al. A simple clinical model for the diagnosis of deep vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med 1998; 243: 15-23.
  29. Bigaroni A., Perrier A., Bounameaux H. Is clinical probability assessment of deep vein thrombosis by a score really standardised? Thromb Haemost 2000; 83: 788-789.
  30. Miron M.J., Perrier A., Bounameaux H. Clinical assessment of suspected deep vein thrombosis: comparison between a score and empirical assessment. J Intern Med 2000; 247: 249-254.
  31. Cornuz J., Ghali W.A., Hayoz D. et al. Clinical perdiction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative d-dimer testing. Am J Med 2002; 112: 198-203.
  32. Musset D., Parent F., Meyer G. et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multi-centre outcome study. Lancet 2002; 360: 1914-1920.
  33. Perrier A., Miron M., Desmarais S. et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism. Arch Intern Med 2000; 160: 512-516.
  34. Barghouth G., Yersin B., Boubaker A. et al. Combination of clinical and V/Q scan assessment for the diagnosis of pulmonary embolism: a 2-year outcome prospective study. Eur J Nucl Med 2000; 27: 1280-1285.
  35. Sanson B., Lijmer J., MacGillavy M. et al. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. Thromb Haemost 2000; 83: 199-203.
  36. Nilsson T., Mare K., Carlsson A. Value of structured clinical and scintigraphic protocols in acute pulmonary embolism. J Intern Med 2001; 250: 213-218.
  37. Miron M.J., Perrier A., Bounameaux H. et al. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalised patients. Eur Respir J 1999; 13: 1365-1370.
  38. Miniati M., Pistolesi M., Marini C. et al. (The PISA-PED Investigators). Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the prospective investigative study of acute pulmonary embolism diagnosis (PISA-PED). Am J Respir Crit Care Med 1996; 154: 1387-1393.
  39. Perrier A., Desmarais S., Miron M. et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-195.
  40. Perrier A., Desmarais S., Goehring C. et al. D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 1997; 156: 492-496.
  41. Kelly J., Hunt B.J. The utility of pretest probability assessment in patients with clinically suspected venous thromboembolism. J Thrombos Haemostas 2003; 1 (9): 1888-1896.
  42. Bayes Thomas, Price Richard (1763). "An Essay towards solving a Problem in the Doctrine of Chance. By the late Rev. Mr. Bayes, communicated by Mr. Price, in a letter to John Canton, M. A. and F. R. S.". Philosophical Transactions of the Royal Society of London 1953: 370-418.
  43. Logic in Medicine. Calbert Phillips, eds. London: BMJ Publishing Group. 1995.
  44. Kelly J.A., Hunt B.J. Role of d-dimers in diagnosis of venous thromboembolism. Lancet 2002; 359: 456-458.
  45. Perone N., Bounameaux H., Perrier A. Comparison of four strategies for diagnosing deep vein thrombosis: cost-effectiveness analysis. Am J Med 2001; 110: 33-40.
  46. Perrier A., Nendaz M.R., Sarasin F.P. et al. Cost-effectiveness analysis of diagnostic strategies for suspected pulmonary embolism including helical computed tomography. Am J Respir Crit Care Med 2003; 167: 39-44.
  47. Molloy W., English J., O'Dwyer R., O'Connell J. Clinical findings in the diagnosis of proximal deep vein thrombosis. Irish Med J 1982; 75: 119-120.
  48. Sandler D.A., Duncan J.S., Ward P. et al. Diagnosis of deep-vein thrombosis: comparison of clinical evaluation, ultrasound, plethysmography, and venoscan with X-ray venogram. Lancet 1984; ii: 716-719.
  49. Haeger K. Problems of acute deep venous thrombosis. Angiology 1969; 20: 219-223.
  50. Singer J. Value of clinical signs of deep venous thrombosis. Lancet 1980; i: 1186.
  51. Richards L., Armstrong J.D., Tikoff G. et al. Noninvasive diagnosis of deep venous thrombosis. Arch Intern Med 1976; 136: 1091-1096.
  52. O'Donnell T.F., Abbott W.M., Athanasoulis C.A., Millan V.G. Diagnosis of deep venous thrombosis in the outpatient by venography. Surg Gynecol Obstetrics 1980; 150: 69-74.
  53. Hoellerich V.L., Wigton R.S. Diagnosing pulmonary embolism using clinical findings. Arch Intern Med 1986; 146: 1699-1704.
  54. Landefeld C.S., McGuire E., Cohen A.M. Clinical findings associated with acute proximal deep vein thrombosis: a basis for quantifying clinical judgement. Am J Med 1990; 88: 382-388.
  55. Wells P., Hirsh J., Anderson D.R. et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 1: 1326-1330.
  56. Wells P.S., Anderson D.R., Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83 (3): 416-420.
  57. Le Gal G., Righini M., Roy P.M. et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144 (3): 165-171.
  58. Erkens P.M., Gandara E., Wells P. et al. Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost 2010; 8: 2412-2417.
  59. Kovacs M.J., Anderson D., Morrow B. et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83: 209-211.
  60. Baglin T. Fifty per cent of patients with pulmonary embolism can betreated as outpatients. J Thromb Haemost 2010; 8: 2404-2405.
  61. Wasson J.H., Sox H.C. Clinical prediction rules. Have they come of age? JAMA 1996; 275: 641-642.
  62. Wyatt J.C., Altman A.D. Prognostic models: clinically useful or quickly forgotten? BMJ 1995; 311: 1539-1541.
  63. Kabrhel C., McAfee A.T., Goldhaber S.Z. The contribution of the subjective component of the Canadian pulmonary embolism score to the overall score in emergency department patients. Acad Emerg Med 2005; 12: 915-920.
  64. Wells P.S., Anderson D.R., Rodger M. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 2001; 135: 98-107.
  65. Kline J.A., Runyon M.S., Webb W.B. et al. Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients. Chest 2006; 129: 1417-1423.
  66. Miniat M., Bottai M., Monti S. Comparison of 3 clinical models for predicting the probability of pulmonary embolism. Medicine (Baltimore) 2005; 84: 107-114.
  67. Penaloza A., Melot C., Dochy E. et al. Assessment of pretest probability of pulmonary embolism in the emergency department by physicians in training using the Wells model. Thromb Res 2007; 120: 173-179.
  68. Wolf S.J., McCubbin T.R., Feldhaus K.M. et al. Prospective validation of wells criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med 2004; 44: 503-510.
  69. van Belle A., Buller H.R., Huisman M.V. et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172-179.
  70. Righini M., LeGal G., Aujesky D. et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomized non-inferiority trial. Lancet 2008; 371: 1343-1352.
  71. Klok F.A., Kruisman E., Spaan J. et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost 2008; 6: 40-44.
  72. Chagnon I., Bounameaux H., Aujesky D. et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med 2002; 113: 269-275.
  73. Wicki J., Perneger T.V., Junod A.F. et al. Assessing clinical probability of pulmonary embolism in the emergency ward. Arch Intern Med 2001; 161: 92-97.
  74. Grifoni S., Olivotto I., Cecchini P. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817-2822.
  75. Kucher N., Rossi E., De Rosa M., Goldhaber S.Z. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005; 165: 1777-1781.
  76. Schoepf U.J., Kucher N., Kipfmueller F. et al. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004; 110: 3276-3280.
  77. Kucher N., Goldhaber S.Z. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108: 2191-2194.
  78. Pieralli F., Olivotto I., Vanni S. et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 2006; 97: 1386-1390.
  79. Becattini C., Vedovati M.C., Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.
  80. Sanchez O., Trinquart L., Colombet I. et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29: 1569-1577.
  81. Wicki J., Perrier A., Perneger T.V. et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84: 548-552.
  82. Aujesky D., Obrosky D.S., Stone R.A. et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-1046.
  83. Aujesky D., Roy P.M., Le Manach C.P. et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27: 476-481.
  84. Jiménez D., Yusen R.D., Otero R. et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132: 24-30.
  85. Konstantinides S., Geibel A., Heusel G. et al. Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150.
  86. Margheri M., Vittori G., Vecchio S. et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am J Cardiol 2008; 101: 252-258.
  87. Vanni S., Nazerian P., Pepe G. et al. Comparison of two prognostic models for acute pulmonary embolism: clinical vs. right ventricular dysfunction-guided approach. J Thromb Haemost 2011; 9 (10): 1916-1923.
  88. Righini M., Roy P.-M., Meyer G. et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011; 9: 2115.
  89. Runyon M.S., Richman P.B., Kline J.A. on behalf of the Pulmonary EmbolismEmergency Medicine Practitioner Knowledge and Use of Decision Rules for the Evaluation of Patients with Suspected Pulmonary Embolism: Variations by Practice Setting and Training Level. Acad Emerg Med 2007; 14 (1): 53-57.
  90. Simon R., Altman D.G. Statistical aspects of prognostic factor studies in oncology [Editorial]. Br J Cancer 1994; 69: 979-985.
  91. Tannock I.F. False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons. J Natl Cancer Inst 1996;88: 206-207.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies